Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CTSD | P07339 | 1/20 | 0.33 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrazine SCHEMBL5179 | 1.00 | — | — | |
| SCHEMBL31437084 | 1.00 | TSHR (0.50) | TSHRNAPRTTDP1LMNAMAPT | |
| Pyrazine SCHEMBL4020461 | 0.93 | — | — | |
| Pyrazine SCHEMBL10496031 | 0.93 | — | — | |
| Pyrazine SCHEMBL5548201 | 0.93 | TSHR (0.46) | TSHRNAPRTTDP1LMNAMAPT | |
| Pyrazine SCHEMBL940753 | 0.93 | — | — | |
| Pyrazine SCHEMBL8535297 | 0.93 | — | — | |
| Pyrazine SCHEMBL21647787 | 0.93 | — | — | |
| Pyrazine SCHEMBL21176400 | 0.93 | — | — | |
| Pyrazine SCHEMBL11336378 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11718587-B2 | Compound, epoxy curing catalyst and method for producing compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| EP-3683210-B1 | COMPOUND, EPOXY CURING CATALYST AND METHOD FOR PRODUCING COMPOUND | TOKYO OHKA KOGYO CO LTD (JP) | 2022-08-24 | — | — | EP | disclosed |
| US-11142629-B2 | Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-10-12 | — | — | US | disclosed |
| US-20200283567-A1 | COMPOUND, EPOXY CURING CATALYST AND METHOD FOR PRODUCING COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-09-10 | — | — | US | disclosed |
| EP-3683210-A1 | COMPOUND, EPOXY CURING CATALYST AND METHOD FOR PRODUCING COMPOUND | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2020-07-22 | — | — | EP | disclosed |
| US-20190300674-A1 | HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-10-03 | — | — | US | disclosed |
| US-20190302026-A1 | Uniform, Functionalized, Cross-Linked Nanostructures for Monitoring pH | WOOLEY KAREN L (US) | 2019-10-03 | — | — | US | disclosed |
| CN-109863151-A | Fused tricyclic pyridazinone compounds for the treatment of orthomyxoviral infections | 诺华股份有限公司 | 2019-06-07 | — | — | CN | disclosed |
| US-20180335385-A1 | Uniform, Functionalized, Cross-Linked Nanostructures for Monitoring pH | THE WASHINGTON UNIVERSITY | 2018-11-22 | — | — | US | disclosed |
| CN-106415912-A | Additive for electrochemical device, and electrolyte, electrode and electrochemical device comprising same | 株式会社LG化学 | 2017-02-15 | — | — | CN | disclosed |
| US-4877883-A | CATIONIC SURFACTANTS | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1989-10-31 | — | — | US | disclosed |
| US-4874850-A | CATIONIC TENSIDES IN MICELLES WITH HYDROPHOBIC PEPTIDES; DRUG DELIVERY | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. (DE) | 1989-10-17 | — | — | US | disclosed |
| US-4870174-A | CATIONIC SURFACTANTS, SMALL CRITICAL MICELLE CONCENTRATIONS | MEDICE CHEM.-PHARM. FABRIK (DE) | 1989-09-26 | — | — | US | disclosed |
| EP-0277270-A2 | N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-08-10 | — | — | EP | disclosed |
| EP-0262343-A2 | N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-04-06 | — | — | EP | disclosed |
| EP-0262344-A2 | N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-04-06 | — | — | EP | disclosed |
| EP-0260428-A2 | Cationic surfactants and pharmaceutical compositions containing them | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-03-23 | — | — | EP | disclosed |
| EP-0260429-A2 | N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-03-23 | — | — | EP | disclosed |
| EP-0258672-A2 | Cationic surfactants and pharmaceutical compositions containing them | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-03-09 | — | — | EP | disclosed |
| EP-0257400-A2 | Pharmaceutical compositions containing cationic surfactants | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200283567-A1 | COMPOUND, EPOXY CURING CATALYST AND METHOD FOR PRODUCING COMPOUND | MSMO1, RIOK1, ME1 | TSHR 4428/4885NAPRT 1178/4885TDP1 4354/4885 |
| US-20190302026-A1 | Uniform, Functionalized, Cross-Linked Nanostructures for Monitoring pH | MUC1, CD44, PFN1 | TSHR 4673/4885NAPRT 3530/4885TDP1 1439/4885 |
| US-11718587-B2 | Compound, epoxy curing catalyst and method for producing compound | MSMO1, RIOK1, ME1 | TSHR 4428/4885NAPRT 1178/4885TDP1 4354/4885 |
| US-20180335385-A1 | Uniform, Functionalized, Cross-Linked Nanostructures for Monitoring pH | MUC1, CD44, PFN1 | TSHR 4673/4885NAPRT 3530/4885TDP1 1439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.